Kết quả tìm kiếm - Ronald Vender

  • Đang hiển thị 1 - 11 kết quả của 11
Tinh chỉnh kết quả
  1. 1
    Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents

    Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents Bằng Anastasia Drakos, Tiago Torres, Ronald Vender

    Được phát hành 2024
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Tapinarof for the treatment of psoriasis

    Tapinarof for the treatment of psoriasis Bằng Sofia Nogueira, Maria Alexandra Rodrigues, Ronald Vender, Tiago Torres

    Được phát hành 2022
    lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)

    Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health... Bằng Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, Ronald Vender, Can Mert, Nithi Tangsirisap, Natalie Haustrup, Gaia Gallo, Christopher Schuster, Patrick M. Brunner

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Psoriasis Prevalence and Severity by Expert Elicitation

    Psoriasis Prevalence and Severity by Expert Elicitation Bằng Kim Papp, Robert Gniadecki, Jennifer Beecker, Jan Dutz, Melinda Gooderham, Chih-ho Hong, Mark G. Kirchhof, C. Lynde, Catherine Maari, Yves Poulin, Ronald Vender

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial

    Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the op... Bằng Diamant Thaçi, Ronald Vender, Menno A. de Rie, Curdin Conrad, David M. Pariser, Bruce Strober, Veerle Vanvoorden, Maggie Haitian Wang, Cynthia Madden, Dirk De Cuyper, Alexa B. Kimball

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Biosimilars for psoriasis: clinical studies to determine similarity

    Biosimilars for psoriasis: clinical studies to determine similarity Bằng Andrew Blauvelt, L. Puig, Sergio Chimenti, Ronald Vender, Murlidhar Rajagopalan, Ricardo Romiti, Lone Skov, Claus Zachariae, Helen Young, Errol P. Prens, Arnon D. Cohen, J. van der Walt, Jashin J. Wu

    Được phát hành 2016
    lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice

    Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice Bằng Arnon D. Cohen, Jashin J. Wu, L. Puig, Sergio Chimenti, Ronald Vender, Murlidhar Rajagopalan, Ricardo Romiti, Claudia de la Cruz, Lone Skov, Claus Zachariae, Helen Young, Peter Foley, Joelle M. van der Walt, Luigi Naldi, Errol P. Prens, Andrew Blauvelt

    Được phát hành 2017
    lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*

    A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded t... Bằng Andrew Blauvelt, C. Leonardi, Boni E. Elewski, Jeffrey Crowley, Lyn Guenther, Melinda Gooderham, Richard Langley, Ronald Vender, Andreas Pinter, C.E.M. Griffiths, Yayoi Tada, Hany Elmaraghy, Renata Gontijo Lima, Gaia Gallo, L. Renda, Russel Burge, S.Y. Park, Baojin Zhu, Kim Papp

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Clinical Goals and Barriers to Effective Psoriasis Care

    Clinical Goals and Barriers to Effective Psoriasis Care Bằng Bruce Strober, Joelle M. van der Walt, April W. Armstrong, Marc Bourcier, André Vicente Esteves de Carvalho, Edgardo Chouela, Arnon D. Cohen, C. Cruz, Charles N. Ellis, A.Y. Finlay, Alice B. Gottlieb, Jóhann E. Guðjónsson, Lars Iversen, C. Elise Kleyn, Craig L. Leonardi, Charles Lynde, Caitriona Ryan, Colin Theng, Fernando Valenzuela, Ronald Vender, Jashin J. Wu, Helen Young, Alexa B. Kimball

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

    Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study Bằng Tiago Torres, L. Puig, Ronald Vender, Charles Lynde, Stefano Piaserico, J.M. Carrascosa, Paolo Gisondi, E. Daudén, Curdin Conrad, Pedro Mendes‐Bastos, Paulo Ferreira, Luíz Leite, Justin D. Lu, Joana Valério, Manfredo Bruni, Francesco Messina, Alessia Nidegger, Mar Llamas‐Velasco, E. del Alcázar, Asfandyar Mufti, Kyra White, Giacomo Caldarola, Laetitia Teixeira, Paolo Romanelli, K. Desai, Spyridon Gkalpakiotis, Marco Romanelli, Jensen Yeung, Miguel Nogueira, Andrea Chiricozzi

    Được phát hành 2021
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

    A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, doubl... Bằng Andrew Blauvelt, Kim Papp, Alice B. Gottlieb, Abel Jarell, Kristian Reich, Catherine Maari, Kenneth B. Gordon, Laura K. Ferris, Richard Langley, Yayoi Tada, Renata Gontijo Lima, Hany Elmaraghy, Gaia Gallo, L. Renda, S‐M. Park, Russel Burge, Jerry Bagel, Ronald Vender, Mark Lomaga, Isabelle Delorme, Chih-ho Hong, Richard Langley, Lorne Albrecht, Lyn Guenther, Catherine Maari, Kim Papp, Kamal Ohson, Kirk Barber, Charles Lynde, Aditya Gupta, Leslie Rosoph, Jean‐Sébastien Gauthier, Melinda Gooderham, Norman Wasel, Mani Raman, Marni Wiseman, David Greenstein, Abel Jarell, C. A. L. Moon, Lani Clark, S. Jazayeri, Michael Bukhalo, Angela Moore, Tiffani K. Hamilton, Aron Gewirtzman, Lydie Hazan, Jeffrey Crowley, Craig Teller, Matthew Zirwas, Stacy Smith, Mark Lee, Stephen K. Tyring, Patricia Lee, Sunil Dhawan, Craig L. Leonardi, Amarilis Perez‐De Jesus, Wendy McFalda, Ellen Frankel, Paul S. Yamauchi, Scott Fretzin, Rocco Serrao, Todd Schlesinger, Scott Gottlieb, Peter Jenkin, Rola Gharib, Steven A. Davis, Navid Nami, Zoe Diana Draelos, Lloyd Godwin, Cindy E. Owen, Megan N. Landis, William Abramovits, Samuel Sanchez‐Rivera, Abby Van Voorhees, David Fivenson, Francisco A. Kerdel, Seth Forman, Jeffrey S. Weinberg, José González-Chávez, Brent Boyce, Linda Stein‐Gold, Charles P. Hudson, Constance Brown, James Coggi, Christina Feser, Rion Forconi, Sandra Johnson, Maximos McCune, Lawrence Green, Vandana Madkan, Dana Maxwell Shipp, Kenneth B. Gordon, Jill Waibel, Oscar Soto‐Raices, Jennifer Cather, Scott Miller, John P. Scott, Douglas Young, Jessica Kaffenberger, Kelley Yokum

    Được phát hành 2019
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: